M ore than 600 million people are estimated to be obese worldwide, 1 which is thought to be primarily a consequence of lifestyles characterized by consumption of energy-dense foods with poor nutritional content and lack of physical activity in the workplace and at home. The high prevalence of obesity is of considerable concern owing to the plethora of its life-threatening sequelae, including type 2 diabetes mellitus, coronary heart disease, and cerebrovascular disease.
risk factors for cardiovascular disease, 5 occurring in part as a consequence of obesity. 6 Nevertheless, people vary in their susceptibility to the cardio-metabolic consequences of excessive weight gain. 7, 8 Hypertriglyceridemia is a heritable trait, with sib-pair concordance of ≈0. 18 9 and broad-sense heritability estimates of ≈0.72 in younger twins and ≈0.28 in older twins. 10 Recent large-scale genome-wide association studies have identified 44 independent loci that are robustly associated with elevated triglyceride concentrations, some of which also associate with coronary artery disease. [11] [12] [13] Interactions between genetic variants and obesogenic lifestyle factors (primarily diet and physical activity) in relation to blood triglyceride concentrations have been explored extensively. 14, 15 Data recently published from 2 Danish cohorts suggest that previously established triglyceride-associated loci modify the association of body mass index (BMI) and triglycerides, 16 but to our knowledge, no independent replication studies have been published.
The purpose of this study was to determine whether established triglyceride-associated loci modify the association of BMI with triglyceride concentrations in middle-aged adults from Sweden and to compare these findings with those from genetically and culturally similar Danish populations. 16 We also sought to determine whether these interaction effects could be accounted for by specific lifestyle factors associated with BMI and whether the interactions are consistent by sex; we sought to elucidate the functional basis to these observations through protein-protein interaction network analyses.
Materials and Methods

Participants
The participants in the Gene-Lifestyle Interactions and Complex Traits Involved in Elevated Disease Risk (GLACIER) Study are residents in the northern Swedish county of Västerbotten. The GLACIER study is nested within the Västerbottens Hälsoundersökning (Västerbotten's Health Survey), which in turn is part of the Northern Sweden Health and Disease Study. 17 Västerbotten's Health Survey is a population-based health screening initiative that since 1985 invited all residents in the county (current population ≈260 000) in the year of their 40th, 50th, and 60th birthdays to their primary healthcare center to attend a comprehensive clinical health examination. Within the GLACIER cohort, baseline examinations were conducted between 1990 and 2010, and 4312 participants had data available for the current analysis after excluding participants with a BMI <18.5 or >70 kg/ m 2 . These exclusions were made because these extreme observations are likely to be erroneous. All participants provided written informed consent at enrollment into the Västerbotten's Health Survey study, and the Umeå regional medical ethical review board approved all relevant aspects of this study.
The Malmö Diet and Cancer Study (MDCS) is a populationbased prospective cohort study from southern Sweden. During 1991 to 1996, all women born between 1923 and 1950 and men born between 1923 and 1945, living in the city of Malmö, were invited to participate. 18, 19 The current analyses were performed in a subgroup of 6103 randomly selected MDCS participants (termed the MDCS Cardiovascular Cohort) who underwent additional phenotyping to study the epidemiology of carotid artery disease between 1991 and 1994. For the current analysis, 5352 participants had data available after excluding participants with BMI <18.5 and >70 kg/m 2 . All participants provided written informed consent at enrollment into the study. The MDCS was approved by the research ethics committee at Lund University.
The discovery studies that reported the weighted genetic risk score (WGRS TG ) interactions were undertaken in 2 Danish cohorts (Inter99 and Health2006 studies). Inter99 is a randomized nonpharmacological intervention study 20 with a main goal of preventing ischemic heart disease. Health examinations of participants aged 30 to 60 years were performed at the Research Center for Prevention and Health in Glostrup, Denmark. Health2006 is a population-based epidemiological study examining general health, diabetes mellitus, and cardiovascular disease in adults aged 18 to 74 years. The study was conducted at the Research Center for Prevention and Health in Glostrup, Denmark. 21 The analyses reported within these studies were undertaken in the respective studies' baseline data sets.
Measurements
For the GLACIER Study, details of many of the measurements have been reported elsewhere. 22 In brief, height (to the nearest cm) and weight (to the nearest 0.1 kg) were assessed with a wall-mounted stadiometer and a calibrated balance-beam scale, respectively. BMI was calculated as weight (kg)/height (m 2 ). Blood was drawn from an antecubital vein after an overnight fast. There were 169 participants who had been fasted for 4 to 8 hours, 25 participants for <4 hours, and 563 participants for whom fasting information was not available. Lifestyle information was collected via a self-administered questionnaire, as described previously. 17 Trained nurses performed all assessments. Serum triglyceride concentrations were determined using a Reflotron bench-top analyzer (Roche Diagnostics Scandinavia AB). All triglyceride values <0.8 mmol/L were set to missing due to the sensitivity of the analyzer. Triglyceride concentrations were adjusted for lipid-lowering medication in the GLACIER Study as described previously. 22 Smoking was coded as 1, 2, 3 for current, former, and never smokers, respectively. Leisure time physical activity during the past 3 months was categorized as exercising: 1, never; 2, sometimes; 3, once per week; 4, 2-3 times a week; 5, >3 times a week. The diet variable was constructed by conducting principal component analysis to obtain a summary factor representing the global dietary intake. Eight macronutrients, that is, carbohydrates, sugar, protein, saturated fat, total fat, fiber, monounsaturated fatty acid, and polyunsaturated fatty acid intakes (expressed in grams per day), were initially included in the principal component analysis. The first principal component, which contrasted carbohydrate and fiber intake against fat intake, was retained and used in subsequent analyses.
In the MDCS, blood was sampled under standardized fasting conditions. Triglyceride concentrations were determined on a DAX 48 automatic analyzer with use of reagents and calibrators from the supplier of the instrument (Bayer AB, Göteborg, Sweden), and anthropometric and demographic data were collected by trained personnel and in a standardized manner, as previously described. 20 Triglyceride concentrations were adjusted for self-reported use of lipid-lowering medication in the MDCS, in a manner that was similar to the GLACIER Study.
Genotyping
In the GLACIER study, DNA was extracted from peripheral white blood cells, and genomic DNA samples were diluted to 4 ng/μL as previously described. 23, 24 Of the 44 triglyceride-associated loci of interest here, 12, 25 one (rs2929282) was not available in the GLACIER Study. The remaining 43 single-nucleotide polymorphisms (SNPs) were genotyped on the Illumina CardioMetaboChip array (Illumina Inc, San Diego, CA). 26 Genotyping success rate exceeded 99%, and no significant deviations from Hardy-Weinberg equilibrium were observed for any of the 43 SNPs (P>0.001). In total, genotype data for 4190 participants was available after quality control in GLACIER.
In the MDCS, the 41 SNPs (rs13238203, rs6065906 were not available) were genotyped using the Illumina HumanOmniExpress BeadChip v. 1. Genotyping was performed at the Broad Institute, Cambridge, MA. During quality control, participants with a call rate of <95%, an inbreeding coefficient of >3 SD away from mean, discordance between inferred and reported sex, duplicate samples, unexpected high proportion of identical by descent sharing, first and second degree relatives, or deviating from the common population structure in the MDCS (exceeding 8 sigma on the first 2 principal components) were excluded from the analysis. Thus after quality control, 5352 participants and a total number of 850 658 SNPs were eligible in the data set. Call rate was >95%, and none of the 41 SNPs deviated from Hardy-Weinberg equilibrium (P>0.001).
Triglyceride-Specific Weighted Genetic Risk Score
To study the cumulative effect of multiple genetic loci on triglyceride concentrations, a WGRS TG was computed for each study participant. We used published effect sizes from the Global Lipids Genetics Consortium meta-analysis for each SNP 25 to weigh the contribution of each risk allele within the WGRS TG , as previously described. 24, 27 The list of SNPs and corresponding allele frequencies are presented in Table I in the Data Supplement. The WGRS TG was scaled to the original GRS variable by dividing each participant's WGRS by the maximum possible WGRS and multiplied by 86 in the GLACIER Study and by 82 in the MDCS (unweighted sum of the number of triglyceride-raising alleles) 27 to facilitate the interpretation of results. The WGRS TG was further stratified into high versus low genetic burden by dichotomizing the score at the median number of risk alleles in each cohort (<44.6 versus ≥44.6 in both cohorts).
Statistical Analysis
Statistical analyses were undertaken using R version 3.1.1. 28 Marginal genetic effects were estimated with generalized linear models by fitting the SNPs, the WGRS TG , and BMI as independent variables, with log-transformed triglyceride concentrations as the dependent variable. Models were adjusted for age, age2, sex, population substructure (first 4 genomic principal components), and fasting time (3 independent indicator variables for fasting:fasting for 4-8 hours, fasting for <4 hours, and missing fasting information were used to adjustment in the aforementioned models). In additional models, analyses were adjusted for education level and lifestyle factors (leisure time physical activity, smoking, and total energy intake in separate models). To test whether these lifestyle factors might underlie the interaction effects with BMI, we tested interactions with these exposures by additionally including the lifestyle×WGRS TG interaction terms in the regression models. We used the Benjamini Hochberg false discovery rate correction 29 for multiple testing (α=0.05) because Bonferroni correction is likely to be overly conservative given existing evidence to support the research questions of interest to this analysis. For stratified analyses, the BMI variable was dichotomized into normal weight (18.5<BMI<25 kg/m 2 ) and overweight or obese (BMI≥25 kg/m 2 ), as per World Health Organization guidelines. 1 For sex-stratified analyses, linear models were fitted for males and females separately. To compare mean triglyceride concentrations between normal and overweight/obese population strata, we used the independent samples t test to calculate mean differences. We also tested 3-way interactions (sex×BMI×WGRS TG ) to determine whether the interaction of BMI and WGRS TG differed by sex, as implied in the prior publication. 16 For this 3-way interaction, BMI and the WGRS TG were scaled to a standard normal distribution (mean=0, variance=1) to overcome inflated variances observed when the interaction was modeled using these variables expressed on their original scales. The following equations for marginal and interaction effects were used in the linear regression models:
Meta-Analysis
We conducted fixed-effect and random-effects meta-analyses using the interaction effect estimates for the 2 Swedish (the GLACIER and the MDC studies) and 2 Danish cohorts (the Inter 99 and the Health 2006 studies). 16 For sex-stratified meta-analyses, we pooled estimates from the GLACIER Study, the MDCS, the Inter99 Study, and the Health2006 Study for males and females separately; to perform these analyses, we used the METAGEN and FOREST functions of the META package in R. The Cochran's Q test and I 2 statistic were used to assess heterogeneity across the 4 cohorts, although we note that this test may be underpowered. 30 
Network Analyses
We used the Human Protein Reference Database 31 to extract relevant protein-protein interaction networks using the Cytoscape software. 32 We mapped genes linked to previously reported BMI-associated 33, 34 and triglyceride-associated 12, 35 loci to the Human Protein Reference Database protein-protein interaction network. Although the genes closest to the index SNPs found through genome-wide association studies are not yet proven to be causal by experimental studies, we made the assumption that genes nearest to the index SNP are, on average, more likely than not to be causally associated with the given phenotypes; thus, we extracted neighboring nodes from the mapped genes to generate a triglyceride-BMI protein interaction network comprising the genes associated with BMI, triglycerides, and their interacting partner genes. The triglyceride-BMI protein interaction network consists of genes that directly connect the 2 phenotypes through directly interacting nodes and those that interact through one intermediate node. We hypothesized that the resulting subnetwork constitutes genes responsible for cross talk between the 2 phenotypes. Pathway enrichment analyses were performed on this subnetwork using the Cytoscape plug-in designed for pathway analyses based on the REACTOME database. 
Association and Interaction of BMI and WGRS TG With Triglyceride Concentrations in the GLACIER Study
In the GLACIER Study, each additional BMI unit (kg/m 2 ) corresponded to a 2.8% higher triglyceride concentration (P=8.4×10 -84 ) and each additional WGRS TG unit (which corresponds to ≈1 risk allele) was associated with 2% higher triglyceride concentrations (P=7.6×10 ). Overall, the WGRS TG and BMI explained 4.2% and 8.1% of the population variance in triglyceride concentrations, respectively. No association was observed between the WGRS TG and BMI (P=0.14)
As illustrated in Figure 2 , the magnitude of association of the WGRS TG with triglyceride concentrations tended to be greater in overweight and obese participants (2.4% higher triglyceride concentration per WGRS TG unit) than in normal weight participants (1.5% higher triglyceride concentration per WGRS TG unit; P interaction =0.056). Overall, the WGRS TG explained 3.4% of the population variance in triglyceride concentrations in normal-weight participants and 5.7% of the population variance in triglyceride concentrations in overweight and obese participants. ). Similarly, each unit increase in BMI associated with 3.7% higher triglyceride concentration (P=1.4×10 -124 ). Coefficients for the MDCS were directionally consistent and similar in magnitude to the ones obtained in the GLACIER Study (Table) . The WGRS TG ×BMI interaction in the MDCS was directionally consistent and similar in magnitude to the one observed in the GLACIER Study (P interaction =0.083; Figure 2 ).
Individual SNP Analyses
In single SNP interaction analyses, none of the individual triglyceride-associated SNPs replicated between GLACIER and the MDCS (P interaction >0.05 for at least 1 of the 2 studies). Five SNPs yielded a P interaction <0.05 when meta-analyzing the 2 studies (Table III in 
WGRS TG ×Lifestyle Interactions in the GLACIER Study
We explored whether lifestyle variables that are correlated with BMI might explain the WGRS TG ×BMI interactions 
Joint Analysis of the Interaction Effect Estimates
Owing to the directionally consistent interaction effects by cohort (I 2 =0%, Cochran's P=0.70), meta-analyzing the WGRS TG ×BMI interaction effect estimates from the GLA-CIER, the MDC, the Inter99, and the Health 2006 studies yielded a highly statistically significant interaction effect estimate (P interaction =6.5×10 -7 ; Figure 3) . The meta-analysis of the 2 Swedish cohorts (independent replication of the Danish results) yielded a statistically significant WGRS TG ×BMI interaction effect estimate (P interaction =6.0×10 -4 ).
Tests of Sex Heterogeneity
In the GLACIER Study, the WGRS TG ×BMI interaction was statistically significant in females (P=0.0014) but not in males (P=0.15; WGRS TG ×BMI×Sex P interaction =0.0084). The sex-stratified WGRS TG ×BMI interaction was directionally consistent in females in the MDC Study and GLACIER studies, but the interaction was not statistically significant in the MDC Study (P interaction =0.11). In the meta-analysis of data from the Swedish cohorts, the WGRS TG ×BMI×sex interaction effect was nominally statistically significant (P interaction =0.03). The results from the sex-stratified meta-analysis of the 4 Scandinavian cohorts showed that in both males and females, the interactions were directionally consistent, but substantially stronger in females (P interaction =6.8×10 -6 ) than in males (P interaction =0.029; Figure 4 ). Considerable heterogeneity was observed in the males-only meta-analysis (I 2 =58.2%, Cochran's P=0.06; Figure 5A ), whereas none was detectable in the female-only meta-analysis (I 2 =0%, Cochran's P=0.75; Figure 5B ). It should be noted though that with only 4 cohorts included in the meta-analyses, these heterogeneity statistics may be unreliable.
30
Cross Talk Between Triglyceride-and BMIAssociated Gene Networks
Network analyses based on biological protein-protein interactions revealed that protein products of BMI-associated and triglyceride-associated genes form 2 separate dense proteinprotein interaction networks connected through neighboring interacting nodes ( Figure 6 ). This analysis suggests that there is significant cross talk between the BMI-associated and the TG-associated gene networks. We found 3 genes, low density lipoprotein receptor-related protein 1B (LRP1B), SH2B adaptor protein 1 (SH2B1), and tubby bipartite transcription factor (TUB) close to BMI-associated loci that directly interact with genes low density lipoprotein receptor-related protein associated protein 1 (LRPAP1), insulin receptor (INSR), and insulin receptor substrate 1 (IRS1) nearest to TG-associated loci. LRP1B interacts with a network of triglyceride-associated genes (Figure 6 ), and 6 of the 9 genes in this network are enriched in the Lipid Digestion, Mobilization, and Transport Reactome pathway (false discovery rate <0.001). In addition, 11 genes close to BMI-associated loci indirectly interact with 14 genes close to TG-associated loci through one intermediate gene ( Figure 6 ).
Discussion
We examined whether established triglyceride-associated loci modify the association of BMI with fasting blood triglyceride concentrations in ≈10 000 adults from Sweden. Although when we initiated these analyses, no other published studies had addressed this research question, a subsequent publication in Danish adults reported congruent results to our own. Therefore, we conducted a meta-analysis of the Swedish and Danish data, and here we report robust epidemiological evidence of interactions between the aggregated genetic susceptibility for hypertriglyceridemia and BMI on triglyceride concentrations. We extended the Danish study by formally testing for and confirming the presence of sex heterogeneous interaction effects, a hypothesis set forth in the original publication but not formally tested. Moreover, we explored whether the WGRS TG ×BMI interaction might reflect underlying interactions with lifestyle factors that correlate with BMI, such as diet, smoking, and physical activity, but found no evidence to this effect. Finally, we undertook network/pathway analysis to shed light on the mechanisms that might underlie the observed interactions, revealing a network of protein-protein interactions that had not previously been described.
Although many common genetic variants have been reliably associated with dyslipidemia, 12, 35 few large studies have assessed gene-lifestyle interactions in relation to these loci. A statistically significant interaction between the lipase, hepatic (LIPC) 514C>T variant and dietary fat intake on plasma highdensity lipoprotein cholesterol was reported in 18 159 men from the Health Professionals Follow-Up Study. 37 A second large observational study from the Women's Health Initiative recently reported associations of 9 loci with high-density lipoprotein cholesterol, of which 7 were observe to interact with physical activity levels to modify high-density lipoprotein cholesterol concentrations, with the strongest signals emerging from the lipoprotein lipase (LPL) rs10096633, LIPC rs1800588, and cholesteryl ester transfer protein, plasma (CETP) rs1532624 loci. 38 The LPL rs10096633 has also been reported to interact with physical activity to modify the risk of myocardial infarction, such that physical inactivity may offset the protective effect of the minor allele. No evidence of interactions on risk of myocardial infarction was observed for the remaining SNPs. 39 Genetics is often discussed in the context of precision medicine; our study does not, however, provide information that could be immediately used to stratify patient populations for treatment because the magnitude of the interaction effect we observed is small, and it may not be causal. Nonetheless, it is possible that as information accumulates on biomarkers that define susceptible population subgroups, these data might be combined to reach a level of clinical utility.
Epidemiological studies such as ours indirectly shed light on the molecular pathways encoded by the selected loci that modulate the effects of obesity on triglyceride synthesis and metabolism. To address this possibility, we conducted protein-protein interaction analyses to explore interactions between the genes close to triglyceride-associated loci and genes close to BMI-associated loci. We found one direct interaction between the LRP1 and LRPAP1 gene products. When we analyzed the genes neighboring those proximal to the loci associated with BMI and triglyceride, 24 gene products were common between the networks for the 2 phenotypes, suggesting 24 indirect protein-protein interactions. The presence of direct and indirect interactions between genes close to BMI-and triglyceride-associated loci might explain the associations between BMI and triglyceride concentrations and why triglyceride-associated variants modify the relationship between BMI and triglyceride concentrations in our study.
Evidence from randomized controlled trials of weight loss interventions show convincingly that weight loss lowers triglyceride concentrations, 40 whereas clinical trials focused on pharmacologically lowering triglyceride concentrations do not support a causal effect of triglycerides on body weight 41 ; thus, the causal direction between these variables is clear. It is possible though that lifestyle correlates of BMI might underlie (confound) the observed interaction; however, analyses conditioning on relevant lifestyle variables did not materially affect our results, and there was no evidence of WGRS TG ×lifestyle interactions. It is also possible that statistical interactions of the nature reported here could be driven by epigenetically triggered biomodality in the BMI distribution, as recently hypothesized. 42 Unlike almost all other biomarkers, genotypes are robust to most forms of confounding; moreover, the direction of putative causal relationships between genotypes and phenotypes can be directly inferred because germline DNA variants do not change in the presence of the environmental exposures of relevance to this study. Thus, the genetic associations observed here are likely to reflect the underlying effect of bodyweight on relationships between the index genotypes (or those in high linkage disequilibrium with the index genotypes) and triglyceride concentrations. The limitations of the study include that it is cross-sectional, and therefore, it is difficult to speculate how this interaction might impact long-term changes in triglyceride concentrations, which is relevant for public health. In addition, although the network analyses based on protein coding genes nearest to triglyceride-and BMI-associated loci help elucidate the underlying biological interactions and cross talk between the genes associated with the 2 phenotypes, more elaborate functional studies are likely needed to adequately characterize these mechanisms.
In summary, we confirm the presence of gene×BMI interactions in relation to triglyceride concentrations in 2 Swedish cohorts and extend previous work by showing that this is unlikely to reflect concurrent gene×lifestyle interactions. We provide empirical evidence that sex further modifies this interaction effect, and we also report the functional annotation of the gene networks that are likely to underpin these interaction effects. Those latter findings highlight molecular pathways encoded by established triglyceride-associated loci that connect obesity and hypertriglyceridemia. 
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